CCDR: Volume 46-4 -April 2020: Respiratory syncytial virus (RSV)
Données et ressources
-
CCDR: Volume 46-04 -April 2020: Respiratory...HTML
-
CCDR: Volume 46-04 -April 2020: Respiratory...HTML
-
CCDR: Volume 46-04 -April 2020: Respiratory...PDF
-
CCDR: Volume 46-04 -April 2020: Respiratory...PDF
-
Overview of the respiratory syncytial virus...HTML
-
Overview of the respiratory syncytial virus...HTML
-
Overview of the respiratory syncytial virus...PDF
-
Overview of the respiratory syncytial virus...PDF
-
Gap analyses to assess Canadian readiness for...HTML
-
Gap analyses to assess Canadian readiness for...HTML
-
Gap analyses to assess Canadian readiness for...PDF
-
Gap analyses to assess Canadian readiness for...PDF
-
Infographic: Summary of RSV vaccine products...HTML
-
Infographic: Summary of RSV vaccine products...HTML
-
Infographic: Summary of RSV vaccine products...PDF
-
Infographic: Summary of RSV vaccine products...PDF
-
Large community mumps outbreak in Manitoba,...HTML
-
Large community mumps outbreak in Manitoba,...HTML
-
Large community mumps outbreak in Manitoba,...PDF
-
Large community mumps outbreak in Manitoba,...PDF
-
Measles surveillance in Canada: 2018HTML
-
Measles surveillance in Canada: 2018HTML
-
Measles surveillance in Canada: 2018PDF
-
Measles surveillance in Canada: 2018PDF
-
Risk factors for drug-resistant tuberculosis...HTML
-
Risk factors for drug-resistant tuberculosis...HTML
-
Risk factors for drug-resistant tuberculosis...PDF
-
Risk factors for drug-resistant tuberculosis...PDF
-
Motivational interviewing: A powerful tool to...HTML
-
Motivational interviewing: A powerful tool to...HTML
-
Motivational interviewing: A powerful tool to...PDF
-
Motivational interviewing: A powerful tool to...PDF
-
Covid-19: ibuprofen should not be used for...HTML
-
Covid-19: ibuprofen should not be used for...HTML
-
Covid-19: ibuprofen should not be used for...PDF
-
Covid-19: ibuprofen should not be used for...PDF
Info additionnelle
| Champ | Valeur |
|---|---|
| Dernière modification | avril 17, 2026, 18:18 (TU) |
| Créé le | avril 17, 2026, 18:18 (TU) |
| criticality_level | [] |
| geographic_scope | [] |
| open_canada_collection | publication |
| open_canada_date_published | 2020-04-02 00:00:00 |
| open_canada_keywords | {"fr": ["vaccin", "Comité consultatif national sur l’immunisation", "CCNI", "immunisation", "VRS", "virus respiratoire syncytial", "oreillons", "éclosion", "incidence", "vaccination", "vaccin ROR", "enquête", "immunité", "Manitoba", "rougeole", "santé en voyage", "surveillance", "élimination de la rougeole", "vaccination", "tuberculose", "Mycobacterium tuberculosis", "épreuve de sensibilité aux médicaments", "résistant à l'isoniazide", "multirésistant", "réticence à la vaccination", "entrevue motivationnelle", "acceptation de la vaccination", "recours à la vaccination", "préoccupations parentales", "covid", "coronavirus"], "en": ["Vaccine", "National Advisory Committee on Immunization", "NACI", "immunization", "RSV", "respiratory syncytial virus", "mumps", "outbreak", "incidence", "vaccination", "MMR vaccine", "investigation", "immunity", "Manitoba", "measles", "travel health", "surveillance", "measles elimination", "vaccination", "tuberculosis", "Mycobacterium tuberculosis", "drug susceptibility test", "isoniazid-resistant", "multidrug-resistant", "vaccine hesitancy", "motivational interviewing", "vaccine acceptance", "vaccine uptake", "parental concerns", "covid", "coronavirus"]} |
| open_canada_subject | ["health_and_safety"] |
| sensitivity_level | unrestricted |
| title_fr | RMTC : Volume 46-4 -avril 2020 : Virus respiratoire syncytial (VRS) |
| update_frequency | P1M |